Prokidney (PROK) Total Non-Current Liabilities (2021 - 2026)
Prokidney's (PROK) quarterly Total Non-Current Liabilities came in at $28.6 million in Q1 2026, down 19.01% year-on-year from $35.3 million in Q1 2025, and down 15.13% on a QoQ basis from $33.7 million in Q4 2025.
Prokidney (PROK) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Total Non-Current Liabilities data on file, last reported at $28.6 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 19.01% year-over-year to $28.6 million in Q1 2026; TTM through Mar 2026 was $28.6 million, a 19.01% decrease from a year earlier, with the FY2025 full-year figure at $33.7 million, down 12.87% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $28.6 million, down from $33.7 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for PROK reached as high as $38.7 million in Q4 2024 and fell as low as $11.6 million in Q3 2022.
- Historically, Total Non-Current Liabilities has averaged $26.5 million across 5 years, with a median of $28.6 million in 2026.
- Across the five-year window, Total Non-Current Liabilities soared 124.18% in 2023 and dropped 19.01% in 2026, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $12.8 million in 2022, then surged by 124.18% to $28.6 million in 2023, then jumped by 35.05% to $38.7 million in 2024, then retreated by 12.87% to $33.7 million in 2025, then slipped by 15.13% to $28.6 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $28.6 million in Q1 2026, $33.7 million in Q4 2025, and $32.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 4.45 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 110.28 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1.98 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 5.87 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 7.32 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 40.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 746.94 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | 28.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.61 Mn |
| Dec 31, 2025 | 33.71 Mn |
| Sep 30, 2025 | 32.31 Mn |
| Jun 30, 2025 | 31.78 Mn |
| Mar 31, 2025 | 35.32 Mn |
| Dec 31, 2024 | 38.69 Mn |
| Sep 30, 2024 | 30.55 Mn |
| Jun 30, 2024 | 26.23 Mn |
| Mar 31, 2024 | 24.16 Mn |
| Dec 31, 2023 | 28.65 Mn |
| Sep 30, 2023 | 23.10 Mn |
| Jun 30, 2023 | 26.78 Mn |
| Mar 31, 2023 | 13.75 Mn |
| Dec 31, 2022 | 12.78 Mn |
| Sep 30, 2022 | 11.56 Mn |
| Dec 31, 2021 | 13.38 Mn |